Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC δ signal transduction

Ju Hyung Woo, Jun Hee Lim, Young Ho Kim, Seong Il Suh, Do Sik Min, Jong Soo Chang, Young Han Lee, Jong Wook Park, Taeg Kyu Kwon

Research output: Contribution to journalArticle

188 Citations (Scopus)

Abstract

Proteolytic degradation of the extracellular matrix and tumor metastasis correlate with the expression of endopeptidases known as matrix metalloproteinases (MMPs). The expression of MMPs is regulated by cytokines and signal transduction pathways, including those activated by phorbol myristate acetate (PMA). We found that resveratrol, a phytoalexin present in grapes, significantly inhibits the PMA-induced increase in MMP-9 expression and activity. These effects of resveratrol are dose dependent and correlate with the suppression of MMP-9 mRNA expression levels. PMA caused about a 23-fold increase in MMP-9 promoter activity, which was suppressed by resveratrol. Transient transfection utilizing MMP-9 constructs, in which specific transcriptional factors were mutagenized, indicated that the effects of PMA and resveratrol were mediated via an activator protein-1 and nuclear factor-κB response element. Resveratrol inhibited PMA-mediated activation of c-Jun N-terminal kinase (JNK) and protein kinase C (PKC)-δ activation. Therefore, we conclude that the MMP-9 inhibition activity of resveratrol and its inhibition of JNK and PKC-δ may have a therapeutic potential, given that a novel means of controlling growth and invasiveness of tumors.

Original languageEnglish
Pages (from-to)1845-1853
Number of pages9
JournalOncogene
Volume23
Issue number10
DOIs
Publication statusPublished - 2004 Mar 11

Fingerprint

JNK Mitogen-Activated Protein Kinases
Matrix Metalloproteinase 9
Tetradecanoylphorbol Acetate
Protein Kinase C
Signal Transduction
Matrix Metalloproteinases
Endopeptidases
Transcription Factor AP-1
Vitis
Response Elements
Extracellular Matrix
Transfection
resveratrol
Neoplasms
Cytokines
Neoplasm Metastasis
Messenger RNA
Growth

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Woo, Ju Hyung ; Lim, Jun Hee ; Kim, Young Ho ; Suh, Seong Il ; Min, Do Sik ; Chang, Jong Soo ; Lee, Young Han ; Park, Jong Wook ; Kwon, Taeg Kyu. / Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC δ signal transduction. In: Oncogene. 2004 ; Vol. 23, No. 10. pp. 1845-1853.
@article{f5f3a719d12843dc87a9e48145bae992,
title = "Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC δ signal transduction",
abstract = "Proteolytic degradation of the extracellular matrix and tumor metastasis correlate with the expression of endopeptidases known as matrix metalloproteinases (MMPs). The expression of MMPs is regulated by cytokines and signal transduction pathways, including those activated by phorbol myristate acetate (PMA). We found that resveratrol, a phytoalexin present in grapes, significantly inhibits the PMA-induced increase in MMP-9 expression and activity. These effects of resveratrol are dose dependent and correlate with the suppression of MMP-9 mRNA expression levels. PMA caused about a 23-fold increase in MMP-9 promoter activity, which was suppressed by resveratrol. Transient transfection utilizing MMP-9 constructs, in which specific transcriptional factors were mutagenized, indicated that the effects of PMA and resveratrol were mediated via an activator protein-1 and nuclear factor-κB response element. Resveratrol inhibited PMA-mediated activation of c-Jun N-terminal kinase (JNK) and protein kinase C (PKC)-δ activation. Therefore, we conclude that the MMP-9 inhibition activity of resveratrol and its inhibition of JNK and PKC-δ may have a therapeutic potential, given that a novel means of controlling growth and invasiveness of tumors.",
author = "Woo, {Ju Hyung} and Lim, {Jun Hee} and Kim, {Young Ho} and Suh, {Seong Il} and Min, {Do Sik} and Chang, {Jong Soo} and Lee, {Young Han} and Park, {Jong Wook} and Kwon, {Taeg Kyu}",
year = "2004",
month = "3",
day = "11",
doi = "10.1038/sj.onc.1207307",
language = "English",
volume = "23",
pages = "1845--1853",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "10",

}

Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC δ signal transduction. / Woo, Ju Hyung; Lim, Jun Hee; Kim, Young Ho; Suh, Seong Il; Min, Do Sik; Chang, Jong Soo; Lee, Young Han; Park, Jong Wook; Kwon, Taeg Kyu.

In: Oncogene, Vol. 23, No. 10, 11.03.2004, p. 1845-1853.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC δ signal transduction

AU - Woo, Ju Hyung

AU - Lim, Jun Hee

AU - Kim, Young Ho

AU - Suh, Seong Il

AU - Min, Do Sik

AU - Chang, Jong Soo

AU - Lee, Young Han

AU - Park, Jong Wook

AU - Kwon, Taeg Kyu

PY - 2004/3/11

Y1 - 2004/3/11

N2 - Proteolytic degradation of the extracellular matrix and tumor metastasis correlate with the expression of endopeptidases known as matrix metalloproteinases (MMPs). The expression of MMPs is regulated by cytokines and signal transduction pathways, including those activated by phorbol myristate acetate (PMA). We found that resveratrol, a phytoalexin present in grapes, significantly inhibits the PMA-induced increase in MMP-9 expression and activity. These effects of resveratrol are dose dependent and correlate with the suppression of MMP-9 mRNA expression levels. PMA caused about a 23-fold increase in MMP-9 promoter activity, which was suppressed by resveratrol. Transient transfection utilizing MMP-9 constructs, in which specific transcriptional factors were mutagenized, indicated that the effects of PMA and resveratrol were mediated via an activator protein-1 and nuclear factor-κB response element. Resveratrol inhibited PMA-mediated activation of c-Jun N-terminal kinase (JNK) and protein kinase C (PKC)-δ activation. Therefore, we conclude that the MMP-9 inhibition activity of resveratrol and its inhibition of JNK and PKC-δ may have a therapeutic potential, given that a novel means of controlling growth and invasiveness of tumors.

AB - Proteolytic degradation of the extracellular matrix and tumor metastasis correlate with the expression of endopeptidases known as matrix metalloproteinases (MMPs). The expression of MMPs is regulated by cytokines and signal transduction pathways, including those activated by phorbol myristate acetate (PMA). We found that resveratrol, a phytoalexin present in grapes, significantly inhibits the PMA-induced increase in MMP-9 expression and activity. These effects of resveratrol are dose dependent and correlate with the suppression of MMP-9 mRNA expression levels. PMA caused about a 23-fold increase in MMP-9 promoter activity, which was suppressed by resveratrol. Transient transfection utilizing MMP-9 constructs, in which specific transcriptional factors were mutagenized, indicated that the effects of PMA and resveratrol were mediated via an activator protein-1 and nuclear factor-κB response element. Resveratrol inhibited PMA-mediated activation of c-Jun N-terminal kinase (JNK) and protein kinase C (PKC)-δ activation. Therefore, we conclude that the MMP-9 inhibition activity of resveratrol and its inhibition of JNK and PKC-δ may have a therapeutic potential, given that a novel means of controlling growth and invasiveness of tumors.

UR - http://www.scopus.com/inward/record.url?scp=1842482424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842482424&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1207307

DO - 10.1038/sj.onc.1207307

M3 - Article

C2 - 14661062

AN - SCOPUS:1842482424

VL - 23

SP - 1845

EP - 1853

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 10

ER -